← Leaderboards
Larry D Cripe
Indiana Univ-Purdue Univ At Indianapolis
$775
Attributed
$775
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $404 · FY2006–08$500$375$250$125$0
'06
'07
'08
Funding mix
By agency
NIH$775 · 3
By mechanism
M01$775 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mitchell Goldman$10,867,864
- David A Williams$57,290,422
- Patrick J Loehrer$17,498,162
- Rebecca J Chan$3,008,970
- Mark R. Kelley$16,203,613
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAspirate SubstanceBiopsy SpecimenBone MarrowClinical Research SiteClinical Trials, Phase IComputer Retrieval Of Information On Scientific Projects DatabaseCytogeneticsDisease RemissionDoseDrug KineticsFollow-UpFundingGrantHematologyHematopathologyInstitutionIntravenous AdministrationLabelLaboratoriesMeasurementMyeloid LeukemiaPartial RemissionPharmacodynamics
Grant awards (3)
SINGLE-CENTER PHASE I STUDY TO DETERMINE THE OPTIMAL BIOLOGIC DOSE OF CC-401$29
M01 · FY2008 · RR · contact PI
SINGLE-CENTER PHASE I STUDY TO DETERMINE THE OPTIMAL BIOLOGIC DOSE OF CC-401$342
M01 · FY2007 · RR · contact PI
ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSION$404
M01 · FY2006 · RR · contact PI